Effects of different anesthetics on the function of plasma exosomes in patients undergoing radical gastrectom

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023034

Enrollment

Unknown

Registered

2019-05-08

Start date

2019-05-15

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

1:propofol

1:sevoflurane

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Elective patients with gastric cancer radical, ASA I - II level.

Exclusion criteria

Exclusion criteria: Long-term use of analgesic drugs, showing drug tolerance; With preoperative infections, immune system and endocrine system disease; Patients who received neoadjuvant chemotherapy, radiotherapy, or blood transfusion treatment before surgery; Receiving any drug (including immune modulators) therapy; Patients with a history of drug allergy to opioids or general anesthetics.

Design outcomes

Primary

Measure	Time frame
exosomes;	—

Countries

China

Contacts

Public ContactChen hong

Department of Anesthesiology, Harbin Medical University Cancer Hospital

517891483@qq.com+86 13945666776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026